Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections. As repeatedly stated by experts around the world, antimicrobial resistance could spell the end of modern medicine. Sepsis costs the US healthcare system $24B+ annually, with more than 2 million new cases a year in the US alone. The risk of death from sepsis increases by as much as 8% for every hour that treatment is delayed, which is why rapid testing is so important.